• Data-Generating AI Platform Conducts Huge Number Of Microbial Experiments

    Bio-IT World | Bioengineers at the University of Michigan (U-M) have seriously scaled up data collection on bacterial species known to affect human health with robots and an artificial intelligence (AI) system that learns from scratch without the need for big databases of knowledge to train on. Dubbed BacterAI, the platform generates its own data and quickly gets smarter by playing a game doling out reward points for accurately predicting the outcome of an experiment.

    Jun 7, 2023

  • Nature-Inspired Orthopedic Implant Coating Kills Bacteria, Monitors Strain

    Bio-IT World | Researchers at the University of Illinois Urbana-Champaign believe they have come up with an attractive approach to the battle against bacteria that can infect orthopedic implants—as well as the surfaces people encounter in everyday life, smartphone screens and kitchen countertops. The smart surgical implant coating contains no chemicals but was instead inspired by the wings of cicadas and dragonflies that are naturally antibacterial through physical interactions.

    Jun 6, 2023

  • ‘The Process Is the Product’ Is No Longer Enough. Now, Data Is the Deliverable

    Bio-IT World | In biomanufacturing, particularly with respect to advanced therapies such as gene and cell therapies, there is a saying: "the process is the product." That insight is still important, but it's also insufficient. As the industry adapts to increasingly complex manufacturing processes, we'd like to propose a reframe: the data is the deliverable. For personalized medicine to reach its potential, leveraging process data to drive learning will be key.

    Jun 1, 2023

  • Follow the Money: Cell Therapy, Genetic Research, Protein-Protein Interactions, More

    Bio-IT World | ElevateBio takes top funding award for Series D round for cell and gene therapy platform; NIH funds research on somatic mosaicism, engineered cell therapy; DOD funds the gathering of more protein-protein interaction data; more.

    May 30, 2023

  • DNA Printing, Bioengineered Kidney Constructs in Space, Revvity’s Big Pharma Agreements, More

    Bio-IT World | The Association for Molecular Pathology releases recommendations for germline variants detected by NGS, 10x Genomics wins German injunction against NanoString Technologies, and Revvity—formerly PerkinElmer—announces new license agreement with AstraZeneca. Plus new products and deployments from DNA Script, Thermo Fisher, Model N, GenScript, and more.

    May 24, 2023

  • Bryn Roberts on Data Citizenship, FAIR Culture, Data Models for the Long Term

    Bio-IT World | Bryn Roberts has spent thirty years in informatics and data, most recently at Roche and before that at AstraZeneca. Now as Global Head of Data and Analytics at Roche Information Solutions, Roberts applies his career-long learnings to the current era of data in life sciences.

    May 23, 2023

  • Bio-IT World Community Names Five New ‘Best of Show’ Products

    Bio-IT World | Earlier this week during the Bio-IT World Conference & Expo, Bio-IT World named five 2023 Best of Show Awards winners including new products from Data Cicada, Genomenon, GitHub, Monomer Bio, and Starfish Storage.

    May 19, 2023

  • New Antimicrobial Susceptibility Test Suggests Generic Z-Pak Can Cure Superbugs

    Bio-IT World | A new antimicrobial susceptibility testing (AST) method developed by scientists at the University of California, Santa Barbara, resolves the longstanding conflict between what the gold-standard assay says will work and actual patient outcomes when it comes to selecting antibiotics. The alternative AST protocol reveals that antibiotics already widely available on the market can cure superbugs.

    May 18, 2023

  • Variation In The Gut Highlights Human Individuality

    Bio-IT World | Anatomical investigations performed on 45 individuals who donated their bodies to science have revealed that the human gut is stunningly diverse based on the size of the organs making up the gastrointestinal (GI) system. Whether those differences are based on what people eat, where they live, or their ancestry is anyone’s guess.

    May 16, 2023

  • Illumina Relaunches Correlation Engine, Banking on Need for ‘Omics Informatics Tools

    Bio-IT World | Illumina is relaunching its BaseSpace Correlation Engine—now simply Illumina Correlation Engine—as the sequencing company emphasizes connecting its informatics components together, Mike LeliveIt, VP of Product Management, told Bio-IT World. “What people want now is for the components to talk to each other so they can get work done and they don’t have to build tools. Our shift to Illumina Connected Software really represents the importance of what we’re building.”

    May 11, 2023

  • Novel Wound Dressing Monitors For Infection In Real Time

    Bio-IT World | Researchers in Sweden who previously introduced a hydrogel wound dressing constructed of nanocellulose that requires no changing have further improved on their innovation with the integration of a pH sensor to passively monitor for early signs of infection. In parallel, they’re working on antimicrobial substances based on lipopeptides that are showing potency against multiple types of bacteria.

    May 10, 2023

  • Bio-IT World Announces Best of Show Finalists, People’s Choice Contenders

    Bio-IT World | Bio-IT World announced the companies contending the for 2023 Best of Show Awards today. Thirty-three new products will be exhibited on the floor for attendees to view at the Bio-IT World Conference & Expo, May 16-18, at the Hynes Convention Center in Boston.

    May 9, 2023

  • Accelerating Implementation: Unlocking the Potential of Next-Generation Sequencing

    Bio-IT World | Next-generation sequencing (NGS) has revolutionized molecular biology and served as a universal tool for many research avenues across the spectrum of biology. With the NGS market expanding, three key barriers—time, cost, and expertise—are holding back the potential of NGS and the full impact it could have on society, diagnostics, and precision medicine.

    May 5, 2023

  • Anastasia Christianson on Pfizer’s Approach to AI, ML, and the Digital Age

    Bio-IT World | At Pfizer, AI plays a key role in every step of the drug discovery process, Anastasia Christianson, Global Head of AI, ML, Analytics, and Data at Pfizer, tells Bio-Team co-founder Stan Gloss on the latest episode of the Trends from the Trenches podcast. Christianson will be the opening keynote at the 2023 Bio-IT World Conference & Expo, May 16-18, 2023, in Boston.

    May 4, 2023

  • Novel Mouse Avatars Could Advance Personalized Medicine For Cancer

    Bio-IT World | Up to now, mouse avatars haven’t proven to be particularly good tools for forecasting treatment response in human cancer patients. But new models being generated by an international team of researchers are expected to be far more predictive of what is going to happen with different cohorts of clinical trial participants.

    May 3, 2023

  • Oxford Nanopore Targets Diagnostics, New Products from Vizgen, Agilent, More

    Bio-IT World | Ginkgo Bioworks acquires an adeno-associated virus capsid discovery and engineering platform; Oxford Nanopore Technologies and bioMérieux SA have teamed up bring nanopore sequencing to the infectious disease diagnostics market, and the emergency of Large Language Models ops. Plus, new products from Metabolon, Cytiva, Vizgen, Agilent, and more.

    Apr 27, 2023

  • PEACE Study Offers New Clues About How Cancer Resists Treatment

    Bio-IT World | Research autopsies are nothing new—the use of post-mortem tissues for cancer research has been ongoing since the end of the nineteenth century—but the Cancer Research UK-sponsored PEACE (posthumous evaluation of advanced cancer environment) study stands apart by virtue of its scope and scale. The pan-cancer initiative intends to enroll 500 patients across the country in hopes of understanding cancer evolution, drug resistance and why patients die of their disease.

    Apr 26, 2023

  • Follow the Money: Multi-omic Drug Discovery, Antibody Manufacturing, Biopolar Focus, More

    Bio-IT World | Big money for small-batch antibodies, investment in understanding bipolar disorder, Mercy BioAnalytics nets Series A for detecting cancer biomarkers on the surface of tumor-derived extracellular vesicles; and more.

    Apr 25, 2023

  • Embracing Automation to Integrate Medical Information and Safety Operations

    Bio-IT World | Businesses depend on data to inform strategy and measure success across all industries. To benefit from automated workflows, life sciences organizations must integrate disparate systems. End-to-end, open architecture solutions facilitate communication between multiple platforms with minimal friction or tedious, time-consuming middle steps.

    Apr 21, 2023

  • Bio-IT World Names 2023 Innovative Practices Winners

    Bio-IT World| Bio-IT World today announced the 2023 Innovative Practices Awards winners. Six projects were honored. Companies involved in the winning entries included AbbVie, Bayer G4A; Carenostics; City of Hope; Generate Biomedicines; Hackensack Meridian Health; Higher Steaks; Regeneron Pharmaceuticals; SciBite; and Synthace.

    Apr 19, 2023